124 related articles for article (PubMed ID: 7812363)
1. In vitro effects of pentoxifylline and doxorubicin on cell survival and DNA damage in sensitive and MDR-P388 leukemia cells.
Viladkar A; Chitnis M
Cancer Biother; 1994; 9(2):143-51. PubMed ID: 7812363
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of DNA biosynthesis by vincristine and pentoxifylline in murine P388 leukemia cells resistant to doxorubicin.
Chitnis MP; Viladkar AB; Juvekar AS
Neoplasma; 1990; 37(6):619-26. PubMed ID: 2274081
[TBL] [Abstract][Full Text] [Related]
3. Sensitization of P388 murine leukemia cells to epirubicin cytotoxicity by reserpine.
Viladkar A; Chitnis M
Cancer Biother; 1993; 8(1):77-85. PubMed ID: 7812352
[TBL] [Abstract][Full Text] [Related]
4. Partial circumvention of P-glycoprotein-mediated multidrug resistance by doxorubicin-14-O-hemiadipate.
Leontieva OV; Preobrazhenskaya MN; Bernacki RJ
Invest New Drugs; 2002 Feb; 20(1):35-48. PubMed ID: 12003193
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of adriamycin-induced cytotoxicity by increasing retention and inhibition of DNA repair in DOX-resistant P388 cell lines with new calcium channel blocker, DMDP.
Bankusli I; Yin MB; Mazzoni A; Abdellah AJ; Rustum YM
Anticancer Res; 1989; 9(3):567-74. PubMed ID: 2764503
[TBL] [Abstract][Full Text] [Related]
6. Identification of two distinct intracellular sites that contribute to the modulation of multidrug resistance in P388/ADR cells expressing P-glycoprotein.
Mayer LD; Lim KT; Hartley D
J Exp Ther Oncol; 2002; 2(2):107-20. PubMed ID: 12415627
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance.
Cuvier C; Roblot-Treupel L; Millot JM; Lizard G; Chevillard S; Manfait M; Couvreur P; Poupon MF
Biochem Pharmacol; 1992 Aug; 44(3):509-17. PubMed ID: 1354963
[TBL] [Abstract][Full Text] [Related]
8. Effects of cis-unsaturated fatty acids on doxorubicin sensitivity in P388/DOX resistant and P388 parental cell lines.
Liu QY; Tan BK
Life Sci; 2000; 67(10):1207-18. PubMed ID: 10954054
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of doxorubicin resistance by pentoxifylline in human chronic myeloid leukemia cells in vitro.
Viladkar A; Juvekar A; Chitnis M; Advani S
Sel Cancer Ther; 1991; 7(3):119-26. PubMed ID: 1771298
[TBL] [Abstract][Full Text] [Related]
10. Enhanced efficacy of 1-methyl-3-propyl-7-butylxanthine on the antitumor activity of doxorubicin against doxorubicin-resistant P388 leukemia.
Sadzuka Y; Sugiyama T; Sawanishi H; Miyamoto K
Cancer Lett; 1999 Apr; 138(1-2):5-11. PubMed ID: 10378767
[TBL] [Abstract][Full Text] [Related]
11. Reversal of resistance to doxorubicin with cepharanthine in murine P388 leukemia cells.
Fujimura T; Shibata H; Maekawa I; Furusawa S; Kawauchi H; Sasaki K; Takayanagi Y
Jpn J Pharmacol; 1990 Dec; 54(4):464-7. PubMed ID: 2087009
[TBL] [Abstract][Full Text] [Related]
12. Modulation of thiol pools by vitamin K3 and its effect on survival of sensitive and resistant murine tumor cells.
Parekh H; Chavan S; Chitnis M
Anticancer Drugs; 1991 Apr; 2(2):159-68. PubMed ID: 1683589
[TBL] [Abstract][Full Text] [Related]
13. Antiproliferative effects of mitoxantrone in ADR-sensitive and ADR-resistant P388 leukemia cells enhanced by vitamin K3.
Parekh H; Chavan S; Chitnis M
Tumori; 1991 Dec; 77(6):484-90. PubMed ID: 1803714
[TBL] [Abstract][Full Text] [Related]
14. Novel cellular determinants for reversal of multidrug resistance in cells expressing P170-glycoprotein.
Yin MB; Guo B; Voigt W; Vanhoefer U; Gibbs JF; Skenderis BS; Frank C; Wrzosek C; Rustum YM
Biochim Biophys Acta; 1998 Mar; 1401(3):265-76. PubMed ID: 9540817
[TBL] [Abstract][Full Text] [Related]
15. Medicarpin and millepurpan, two flavonoids isolated from Medicago sativa, induce apoptosis and overcome multidrug resistance in leukemia P388 cells.
Gatouillat G; Magid AA; Bertin E; El btaouri H; Morjani H; Lavaud C; Madoulet C
Phytomedicine; 2015 Dec; 22(13):1186-94. PubMed ID: 26598918
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of pirarubicin cytotoxicity by dipyridamole in doxorubicin-resistant mouse P388 leukemia cells.
Furusawa S; Fujimura T; Kawauchi H; Sasaki K; Takayanagi Y
Res Commun Chem Pathol Pharmacol; 1991 Mar; 71(3):321-36. PubMed ID: 2047575
[TBL] [Abstract][Full Text] [Related]
17. Effects of xanthine derivatives on the influx and efflux of doxorubicin in P388 and DOX-resistant P388 leukemia cells.
Sadzuka Y; Egawa Y; Sawanishi H; Miyamoto K; Sonobe T
Toxicol Lett; 2002 Sep; 135(1-2):137-44. PubMed ID: 12243872
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells.
Ling YH; Priebe W; Perez-Soler R
Cancer Res; 1993 Apr; 53(8):1845-52. PubMed ID: 8467504
[TBL] [Abstract][Full Text] [Related]
19. Circumvention of adriamycin resistance: effect of 2-methyl-1,4-naphthoquinone (vitamin K3) on drug cytotoxicity in sensitive and MDR P388 leukemia cells.
Parekh HK; Mansuri-Torshizi H; Srivastava TS; Chitnis MP
Cancer Lett; 1992 Jan; 61(2):147-56. PubMed ID: 1730138
[TBL] [Abstract][Full Text] [Related]
20. Prevention of MDR development in leukemia cells by micelle-forming polymeric surfactant.
Sharma AK; Zhang L; Li S; Kelly DL; Alakhov VY; Batrakova EV; Kabanov AV
J Control Release; 2008 Nov; 131(3):220-7. PubMed ID: 18722489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
